Category: drug
-
Sniffer Dogs and Drones: Canada Flexes Drug Enforcement Muscle in Appeal to Trump
•
Bread path links PMN Business Canada is circulating the usual American -style boldness in an attempt to prove US President Donald Trump that it is serious about strengthening the borders because it tries to avoid customs tariffs. The author of the article: Bloomberg News Randy Thanga Knight Posted 01 March…
-
Salesforce Stokes Veeva Fight by Snagging Drug Customers
•
(Bloomberg) — Salesforce Inc. says… It is attracting several large clients from its former partner Veeva Systems Inc. There is increasing competition to sell software to the pharmaceutical industry. Most read from Bloomberg More than 40 customers, including the “big three leading global pharmaceutical companies,” have signed deals to use…
-
Teva jumps sharply on bowel disease drug results
•
Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa The stock price opened 20% higher on Wall Street after the Israeli company announced positive results from the phase 2 clinical trial of Docavitog, which it is developing with Sanofi, to treat ulcerative colitis (UC) and Crohn’s disease (CD).…
-
Twice-yearly shot of this drug could help end AIDS
•
It has been described as the closest the world has ever come to a vaccine against the coronavirus AIDS Virus. the Shot twice a year It was 100% effective in preventing HIV infection in a study in women, and results published Wednesday showed it was almost as effective in men.…
-
AbbVie tumbles after new schizophrenia drug fails two trials
•
(Bloomberg) — AbbVie Inc. shares fell. (ABBV) fell by the most in three years after two mid-stage trials of its schizophrenia drug failed to meet their primary target, a blow to the company’s $8.7 billion acquisition of Cerevel Therapeutics earlier this year. . Most read from Bloomberg AbbVie said Monday…
-
Aptar Pharma buys Israeli drug delivery co SipNose
•
The Yokneam-based company has developed an intranasal drug delivery system to precisely target areas of the nasal cavity to enable systemic, local or even direct delivery to the brain. American drug delivery company Aptar Pharma announced the acquisition of the device technology assets of an Israeli company SipNose nasal delivery…
-
Roche falls while Novo, Lilly gain on weight-loss drug report (OTCQX:RHHBY)
•
HJBC Roche (OTCQX: RHHBY) shares fell 5% on Wednesday while shares of rivals Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) gained ground after Reuters reported that positive data from Roche (OTCQX:RHHBY) in July The obesity drug candidate CT-996 was based on just six study participants. In July, Roche said a…
-
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials By Reuters
•
By Ludwig Berger (Reuters) – Sanofi Nasdaq:NASDAQ:NASDAQ:MSN’S most advanced multiple sclerosis drug failed to meet the main goal of two late-stage trials to treat recurrent forms of the disease, dimming the prospects for a broad class of drugs. The French drugmaker said on Monday that two phase 3 trials showed…
-
GSK to seek dismissal of Florida case against heartburn drug Zantac By Reuters
•
(Reuters) – British drugmaker GSK said on Friday it will seek to dismiss an upcoming Zantac lawsuit in Florida where plaintiffs alleged the company’s discontinued heartburn drug caused prostate cancer. The move follows a Florida court ruling Thursday in favor of GlaxoSmithKline and other defendants that threw out expert testimony…
-
Viking obesity drug to rival Eli Lilly’s: report (NASDAQ:VKTX)
•
Carolina Rhoda/iStock via Getty Images Eli Lilly (NYSE:LLYPopular obesity treatment Zepbound could face direct competition from Viking TherapeuticsNASDAQ:VKTX), with the latter expected to launch its flagship weight loss product VK2735 within the next few years, according to data analytics firm GlobalData. He said this week. The prediction comes after the…
-
US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters
•
(Reuters) – The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors linked to combination versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalization, that may have been linked to overdoses caused…
-
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion By Reuters
•
(Reuters) – Eli Lilly and Company said on Monday it will acquire Morphek Holdings Inc (NASDAQ:MLS) for $3.2 billion in cash, giving the U.S. drugmaker access to an experimental drug for a type of inflammatory bowel disease. Shares of drug developer Morphek surged 76% to $56.15 premarket after Lilly’s offer…
-
New Alzheimer’s drug treatment from Eli Lillly wins FDA approval
•
Eli Lilly & Co. has won U.S. approval for an Alzheimer’s treatment, the second drug to slow the progression of the brain-robbing disease that affects 6 million Americans. It’s a huge win for Lilly and its investors, who have been eagerly awaiting the drug since it hit the market. show…
-
Crypto Deposits to Chinese Drug Producers’ Addresses Double in Early 2024 Compared to 2023
•
Blockchain intelligence firm TRM Labs revealed that cryptocurrency deposits at cryptocurrency addresses linked to Chinese drug precursor manufacturers more than doubled in the first four months of 2024 compared to the same period in 2023. In 2023, Chinese precursor networks received over $26 million worth of cryptocurrencies, with 97% of…
-
Crypto Deposits to Chinese Drug Producers’ Addresses Double in Early 2024 Compared to 2023
•
Blockchain intelligence firm TRM Labs revealed that cryptocurrency deposits at cryptocurrency addresses linked to Chinese drug precursor manufacturers more than doubled in the first four months of 2024 compared to the same period in 2023. In 2023, Chinese precursor networks received over $26 million worth of cryptocurrencies, with 97% of…
-
Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate
•
JHVEPhoto/iStock Editorial via Getty Images Merc (New York Stock Exchange: Merck) and its Sichuan partner Kelun-Biotech reported that phase III data on its antibody drug candidate Sacituzumab tirumotecan (sac-TMT) led to a 69% reduction in the risk of progression or death in people with triple-negative breast cancer. From 233 Of…
-
US DOJ Seizes $100M In Crypto From Major Dark Web Drug Trafficking Operation
•
at recent days campaign In connection with illicit transactions involving crypto assets, the US Department of Justice (DOJ) arrested Roy Siang Lin, a 23-year-old from Taiwan. Lin, who also goes by the names Pharoah and Faro, is accused of owning and operating a dark web drug market known as “Incognito…
-
BioAtla reports promising data in cancer drug trials By Investing.com
•
BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck cancer and is preparing for FDA guidance on…
-
Teva schizophrenia drug Phase III results excite analysts
•
Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa) saw its share price rise by 12.8% yesterday, amid high trading volume, to its highest level in five years. The stock price of $15.74 gave it a market value of $17.8 billion, after the company reported first-quarter results with…
-
Schrodinger gets rights to cancer drug candidate back from Bristol
•
koto_feja Bristol-Myers Squibb (New York Stock Exchange: BMI) Rights to its preclinical cancer drug candidate, an SOS1 inhibitor, have been returned to Schrödinger (Nasdaq:SDGR). Schrödinger noted that he had submitted a candidate for development, and Bristol was conducting IND-enabled studies on it. The two companies Their collaboration began in 2020,…